Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
12/31/1996 | US5589338 Nucleic acids encoding a mutant form of human serum albumin involved in familial dysalbuminemic hyperthyroxinemia |
12/31/1996 | US5589185 Nonsteroidal antiinflammatory agents |
12/31/1996 | US5589184 Pharmaceutical compositions and methods of treatment of the cornea following laser treatment |
12/31/1996 | US5589174 Anti-human influenza virus antibody |
12/31/1996 | US5589173 Anticoagulants |
12/31/1996 | US5589171 Treatment of Dupuytren's disease with collagenase |
12/31/1996 | US5589170 Antiinflammatory agent |
12/31/1996 | US5589169 Topical application of tissue plasminogen activator |
12/31/1996 | US5589167 Excipient stabilization of polypeptides treated with organic solvents |
12/31/1996 | US5589154 Diagnosing presence of b-amyloid peptide |
12/31/1996 | US5588422 Methods and pharmaceutical compositions for enhanced cardiopulmonary resuscitation |
12/31/1996 | CA2180280A1 Adenyl-cyclase-hemolysin (ac-hly)-protecting epitopes; use thereof for the treatment or the prevention of infections by bordetella |
12/31/1996 | CA2019745C Preparation for treating and preventing thromboses and thromboembolic complications, use of such a preparation and a method of producing the same |
12/31/1996 | CA1338824C Hypoglycemic and growth-promoting agent isolated from bacitracin |
12/31/1996 | CA1338818C Immunotoxins |
12/29/1996 | CA2180193A1 Enhancing host immunity against viral infections |
12/29/1996 | CA2180079A1 Use of balhimycin as production promoter in animals, and production promoter compositions |
12/27/1996 | WO1996041887A1 Dnase-active protein |
12/27/1996 | WO1996041883A1 Plasmin-resistant streptokinase |
12/27/1996 | WO1996041880A1 Adherence gene from helicobacter pylori and polypeptide coded thereby |
12/27/1996 | WO1996041878A1 Nucleic acid molecule and its uses in determining pathogenicity of staphylococcus |
12/27/1996 | WO1996041870A1 Hydrosoluble compositions of stabilized collagenase and the process for their preparation |
12/27/1996 | WO1996041868A2 Prothrombin derivatives |
12/27/1996 | WO1996041818A1 Chitin hydrogels, methods of their production and use |
12/27/1996 | WO1996041816A1 Factor ix binding peptides, derived from factor viii and their use as inhibitors of blood coagulation |
12/27/1996 | WO1996041815A2 CONJUGATES OF αMSH WITH A FATTY ACID, PREPARATION METHOD THEREFOR, AND USE THEREOF AS A DRUG |
12/27/1996 | WO1996041814A1 Peptide, bronchodilator and blood flow ameliorant |
12/27/1996 | WO1996041644A1 Oral remedy for rheumatoid arthritis and functional food |
12/27/1996 | WO1996041643A1 Antiviral method and antiviral agent |
12/27/1996 | WO1996041642A1 Stable freeze-dried composition containing tpo |
12/27/1996 | WO1996041641A1 Pharmaceutical compositions with analgesic activity |
12/27/1996 | WO1996041640A1 Bradykinin analogs as selective thrombin inhibitors |
12/27/1996 | WO1996041639A1 Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells |
12/27/1996 | WO1996041638A1 Calpain inhibitors for the treatment of neurodegenerative diseases |
12/27/1996 | WO1996041624A1 TNF-α CONVERTING ENZYME |
12/27/1996 | WO1996041620A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells |
12/27/1996 | WO1996041609A2 Methods and compositions for stimulating neurite growth |
12/27/1996 | WO1996041607A2 Pharmaceutical compositions comprising restrictin p/activin a and use thereof as antagonist of il-6 and/or il-11 |
12/27/1996 | WO1996041523A1 Fgf9 as a specific ligand for fgfr3 |
12/27/1996 | WO1996035784A3 Chromatin-regulator genes |
12/27/1996 | WO1996035715A3 Pcna binding substance |
12/27/1996 | WO1996031607A3 Use of an 'immunodeficiency-virus suppressing lymphokine (isl)' to inhibit the replication of viruses, in particular of retroviruses |
12/27/1996 | WO1996031525A3 Inhibitors of farnesyl-protein transferase |
12/27/1996 | WO1996030395A3 Cysteine protease inhibitor |
12/27/1996 | WO1996021731A3 Stabilized external guide sequences |
12/27/1996 | EP0750044A2 DNA constructs and transfection of cells therewith for homologous recombination |
12/27/1996 | EP0750039A1 Immunoregulatory protein LST-1 |
12/27/1996 | EP0750038A2 A mutant gene causing a defect in mitochondrial recombination and a method for its detection |
12/27/1996 | EP0750037A2 TNF-convertase and method measuring inhibition of TNF convertase |
12/27/1996 | EP0749979A2 Method and composition for treating thrombosis |
12/27/1996 | EP0749582A1 Methods of diagnosing and treating preeclampsia |
12/27/1996 | EP0749496A1 Human dna mismatch repair proteins |
12/27/1996 | EP0749494A1 Compositions for the inhibition of tnf formation and uses thereof |
12/27/1996 | EP0749488A1 Anti-il-8 monoclonal antibodies for treatment of inflammatory disorders |
12/27/1996 | EP0749485A1 ANTIMICROBIAL PROTEINS FROM $i(ARALIA) AND $i(IMPATIENS) |
12/27/1996 | EP0749484A1 COORDINATE $i(IN VIVO) GENE EXPRESSION |
12/27/1996 | EP0749481A1 Humanized monoclonal antibodies against human interleukin-4 |
12/27/1996 | EP0749478A1 Yeast strains and modified albumins |
12/27/1996 | EP0749477A1 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
12/27/1996 | EP0749476A1 Mediators of chronic allograft rejection |
12/27/1996 | EP0749475A1 Use of the cytokine ip-10 as an anti-tumor agent |
12/27/1996 | EP0749472A1 Extracorporeal cell culture and transplantation kits |
12/27/1996 | EP0749447A1 Water-soluble dextran fatty acid esters and their use as solubilisers |
12/27/1996 | EP0749445A1 Antibodies which bind the g-csf receptor extracellular domain and methods of treatment |
12/27/1996 | EP0749444A1 Hybrid human/animal factor viii |
12/27/1996 | EP0749442A1 ISOLATED p27 PROTEIN AND ITS ENCODING NUCLEIC ACID MOLECULES |
12/27/1996 | EP0749441A1 Expression and purification of cloned human alpha-fetoprotein |
12/27/1996 | EP0749440A1 Method of isolating and purifying a biomacromolecule |
12/27/1996 | EP0749439A1 Nucleotide or nucleoside photoaffinity compound modified antibodies, methods for their manufacture and use thereof |
12/27/1996 | EP0749325A1 Bispecific molecules having clinical utilities |
12/27/1996 | EP0749323A1 Methods for modulating t cell unresponsiveness |
12/27/1996 | EP0749322A1 VACUOLATING TOXIN-DEFICIENT $i(H. PYLORI) AND RELATED METHODS |
12/27/1996 | EP0749320A1 Fibrin-specific antibody for use as an antithrombotic agent |
12/27/1996 | EP0749318A1 Method of stimulating hematopoiesis with hemoglobin |
12/27/1996 | EP0749317A1 Therapeutic uses of bactericidal/permeability-increasing protein dimer products |
12/27/1996 | EP0749316A1 Antithrombotic agents |
12/27/1996 | EP0749312A1 $i(DIROFILARIA IMMITIS) Gp29 PROTEINS, NUCLEIC ACID MOLECULES AND USES THEREOF |
12/27/1996 | EP0749305A1 Process for making avermectin/zein compositions |
12/27/1996 | EP0749302A1 Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof |
12/27/1996 | EP0664833B1 Therapeutic anti-hiv oligonucleotide and pharmaceutical |
12/27/1996 | EP0633784B1 Hepatitis vaccins containing 3-0 deacylated monophosphoryl lipid A |
12/27/1996 | EP0332651B2 Method of isolating ca 125 antigen |
12/27/1996 | CA2253496A1 Adherence gene from helicobacter pylori and polypeptide coded thereby |
12/27/1996 | CA2224721A1 Calpain inhibitors for the treatment of neurodegenerative diseases |
12/27/1996 | CA2224634A1 Prothrombin derivatives |
12/27/1996 | CA2224253A1 Chitin hydrogels, methods of their production and use |
12/27/1996 | CA2224229A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells |
12/27/1996 | CA2223749A1 Stable tpo-containing lyophilized compositions |
12/27/1996 | CA2222430A1 Methods and compositions for stimulating neurite growth |
12/27/1996 | CA2221567A1 Factor ix binding peptides, derived from factor viii and their use as inhibitors of blood coagulation |
12/25/1996 | CN1138865A Peptides and methods against psoriasis |
12/25/1996 | CN1138864A New compsn. of glycoprotein isoforms having follicle stimulating |
12/25/1996 | CN1138863A Chimeric proteins which block complement activation |
12/25/1996 | CN1138483A Fibre proteinogen compound and its prepn. method |
12/24/1996 | US5587490 Method of inactivation of viral and bacterial blood contaminants |
12/24/1996 | US5587470 3-deazapurines |
12/24/1996 | US5587469 Oligonucleotides containing N-2 substituted purines |
12/24/1996 | US5587468 High affinity nucleic acid ligands to HIV integrase |
12/24/1996 | US5587460 Controller of cell differentiation; immunology |
12/24/1996 | US5587459 Linked to a ligand targeting a cell surface receptor; for treating cancers and autoimmune diseases |